These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

578 related items for PubMed ID: 11066662

  • 1. Patent fight sparks biological warfare in the drug industry.
    Fortune; 2000 Jul 24; 142(3):40, 42. PubMed ID: 11066662
    [No Abstract] [Full Text] [Related]

  • 2. Patent crunch pending.
    Wadman M.
    Nature; 2007 Oct 11; 449(7163):651. PubMed ID: 17968400
    [No Abstract] [Full Text] [Related]

  • 3. Biotech patents-business as usual?
    Lawrence S.
    Nat Biotechnol; 2008 Dec 11; 26(12):1326. PubMed ID: 19060861
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Putting your best mode forward.
    Tsao YR, Tabtiang RK.
    Nat Biotechnol; 2000 Oct 11; 18(10):1113-4. PubMed ID: 11017054
    [No Abstract] [Full Text] [Related]

  • 6. Pharmaceutical patent life-cycle management after KSR v. Teleflex.
    Furrow ME.
    Food Drug Law J; 2008 Oct 11; 63(1):275-320. PubMed ID: 18561462
    [No Abstract] [Full Text] [Related]

  • 7. US policy may encourage counterfeit drugs.
    Bouchie A.
    Nat Biotechnol; 2003 Feb 11; 21(2):121. PubMed ID: 12560826
    [No Abstract] [Full Text] [Related]

  • 8. Hatch-waxman changes debated.
    Chahine K.
    Nat Biotechnol; 2000 Jul 11; 18(7):710-1. PubMed ID: 10888831
    [No Abstract] [Full Text] [Related]

  • 9. Proposed changes to patent code loom over biotech industry.
    Coombs A.
    Nat Biotechnol; 2007 Dec 11; 25(12):1333-4. PubMed ID: 18066010
    [No Abstract] [Full Text] [Related]

  • 10. Cabilly patent finale.
    Waltz E.
    Nat Biotechnol; 2008 Aug 11; 26(8):846. PubMed ID: 18688222
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Patent prosecution of biotechnology and pharmaceutical patents in a changing legal landscape.
    Lu DL, Kowalski TJ, Jarecki-Black J.
    Future Med Chem; 2010 Jan 11; 2(1):7-9. PubMed ID: 21426040
    [No Abstract] [Full Text] [Related]

  • 13. Roche faces charges over Taq patent claim.
    Abbott A.
    Nature; 1996 Aug 22; 382(6593):660. PubMed ID: 8751427
    [No Abstract] [Full Text] [Related]

  • 14. Intellectual property. Decision on NFkappaB patent could have broad implications for biotech.
    Garber K.
    Science; 2006 May 12; 312(5775):827. PubMed ID: 16690824
    [No Abstract] [Full Text] [Related]

  • 15. US courts narrow patent exemptions.
    Fox JL.
    Nat Biotechnol; 2003 Aug 12; 21(8):834. PubMed ID: 12894182
    [No Abstract] [Full Text] [Related]

  • 16. [Patent rights and the free research. The boundary between basic research and private sector is not longer razor-sharp].
    Westerlund L.
    Lakartidningen; 2003 Aug 12; 102(39):2737. PubMed ID: 16245544
    [No Abstract] [Full Text] [Related]

  • 17. Biotech battle royale. Two firms fight over billion-dollar drug.
    Sherrid P.
    US News World Rep; 2000 Mar 20; 128(11):52. PubMed ID: 10848209
    [No Abstract] [Full Text] [Related]

  • 18. Patently absurd?
    Garber K.
    Nat Biotechnol; 2006 Jul 20; 24(7):737-9. PubMed ID: 16841046
    [No Abstract] [Full Text] [Related]

  • 19. "Ganske" threatens biotechnology patents worldwide.
    Glaser V.
    Nat Biotechnol; 1997 Feb 20; 15(2):121. PubMed ID: 9035128
    [No Abstract] [Full Text] [Related]

  • 20. Patent watch: Progress in three key patent disputes in 2009.
    Nat Rev Drug Discov; 2010 Jan 20; 9(1):12-3. PubMed ID: 20050395
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.